MPO and heart failure: Hypercoagulability mediated by leukocytes, especially neutrophils, and myocardial toxicity mediated by various inflammatory mediators and enzymes, such as elastase, myeloperoxidase, and acid phosphatase, contribute to adverse outcomes such as heart failure in patients with STEMI.